Hematonews

Hematología, Medicina, Salud, Noticias, arte, cultura, literatura, novela, gadgets,cine, musica, France

[Hematonews @hematonews]

Certificación de las Clínicas de Hemofilia en el Hospital General de México en niños y adultos.
Federacion Mundial de Hemofilia y Federacion de Hemofilia de la Republica Mexicana.
Un logro para los profesionales de salud del Hospital General de México.
Hematoteam HGM
#hemofilia

[Hematonews @hematonews]

Ganadores en Trabajos Libres en el III Congreso hemato-Academy y XI Congreso Internacional de Hemostasia y Trombosis.
Mérida Yucatán 2026.
Aurora de la Peña Díaz (2), Ma Lourdes Basurto Acevedo (2), Wendy Aguilera Caldera, Ana Paula Cedillo Balandrán.
Felicidades 🍾🎈🎊

[Hematonews @hematonews]

#NuevaFotoDePerfil

[Hematonews @hematonews]

The Special Lecture about Von Willebrand Disease in the IsTH. Wonderful session. Prof David Lillicrap from Canada.
👇🏻
Link: https://t.co/QtgaH1J7cA
(Summary AI)

#ISTH #Paris #France  #vonwillebrand #hemostasis #hematonews

[Hematonews @hematonews]

ISTH in Paris.
Colleagues from Mexico, the best team
#isth #paris #France #hemostasis #thrombosis

[Hematonews @hematonews]

An honor to coincide with one of the greatest opinion leaders in Coagulation of the world. Prof. Pier Mannuccio Mannucci from Milan, Italy.
#ISTH #Paris #France #hemostasisandthrombosis #coagulation @mannucci

[Hematonews @hematonews]

Marstacimab (HYMPAVZI), one of the new drugs for the treatment of hemophilia B, and A. Inhibitor to TFPI, one of the new drugs for the treatment of hemophilia already. #marstacimab #ISTH #paris #france

[Hematonews @hematonews]

International Congress on Thrombosis and Hemostasis (ISTH) in Paris, France.
Friends And colleagues.
#IsTH #paris #france #coagulation #hemostasis

[Hematonews @hematonews]

Excellent research work on causing a decrease in plasminogen for the treatment of some hemorrhagic disorders. New therapies.
#isth #paris #france #bleeding #plasminogen #research #hemostasis #hematonews

[Hematonews @hematonews]

Prof Bertrand Godeau, Hôpital Monroe, Paris. France.
#isth #paris #france #ITP #splenectomy #hemostasis

[Hematonews @hematonews]

At the International Congress of Thrombosis and Hemostasis (ISTH) with Dr. Maria Teresa Alvarez Roman, president of the Spanish Society of Hemostasis and Thrombosis (SEHT). An honor to be in.
#Isth #seth #paris #hemostasis #coagulation #hemostasis #mexico #spain

[Hematonews @hematonews]

ITP session and treatment strategies. Excellent symposium coordinated by Prof. Godeau. Many options for patients who do not respond. Rituximab, TPO, Fostamatinib, BTKi.- #ISTH #ITP #hematonews #Paris

[Vincent Rajkumar @VincentRK]

Just out: Chronic myeloid leukemia: the definitive CML review and current treatment algorithms by @FadiHaddad_MD @DrHKantarjian @BloodCancerJnl #OpenAccess

https://t.co/U28uIP1Ltc

[Benlazar S M A @smbenlazar]

ANTITHROMBOTIC AND CYTOREDUCTION STRATEGIES IN MYELOPROLIFERATIVE NEOPLASM–ASSOCIATED SPLANCHNIC VEIN THROMBOSIS https://t.co/VUd3TO3CHo #EHA26 #mpnsm

[Benlazar S M A @smbenlazar]

2001–2026: LEUKEMIA celebrates 25 years of tyrosine kinase inhibitors >>>From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia https://t.co/CylMHmnKoI #leusm

[Greg Roloff @RoloffGreg]

Consensus Recommendations for CAR T-Cell Administration in Adult Acute Lymphoblastic Leukemia: a Modified Delphi Study
https://t.co/FqxE1GAw56

[Vincent Rajkumar @VincentRK]

Most important #ASCO26 myeloma abstract. Practice changing. Majestec-9 trial.

PFS significantly better with Teclistmaab vs PVd/Kd (HR, 0.29; 95% CI, 0.23–0.38; P<0.0001); 18-mo PFS rate: 69.8% vs 26.9%.

OS significantly better with Tec vs PVd/Kd (HR, 0.60; 95% CI, 0.43–0.83; P=0.002)

Based on this, teclistamab now becomes the leading first choice along with ciltacel for relapsed myeloma in dara refractory patients.

https://t.co/prY0QbS7nM

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Outstanding contribution led by Dr @IvanCivettini and the Humanitas team published in @NEJMEvidence which we at @YaleCancer were happy to be a part of it! Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution | NEJM Evidence https://t.co/VtNUJVRoqh

[Uriel Suárez @UsuarezMD]

Current Volume | ASCO Educational Book 2026 https://t.co/57Q3w048Ca

[Mohamad Mohty @Mohty_EBMT]

SUCCESSOR-2: where success met Mezigdomide and when success becomes Meziurable.! #ASCO26 @TheIACH @COMyCongress